Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host.
J Allergy Clin Immunol Pract. 2019 Jun 13;:
Authors: Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ
Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.
PMID: 31253580 [PubMed - as supplied by publisher]